(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research.
(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research.